1h Free Analyst Time
The narcolepsy drugs market is forecasted to grow by USD 1.80 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the narcolepsy drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising product launches and clinical trials, rising cases of narcolepsy in adults, and rising number of studies to understand cause and treatment of narcolepsy.
The narcolepsy drugs market is segmented as below:
By Type
- Narcolepsy with cataplexy
- Narcolepsy without cataplexy
- Secondary narcolepsy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the narcolepsy drugs market covers the following areas:
- Narcolepsy drugs market sizing
- Narcolepsy drugs market forecast
- Narcolepsy drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global narcolepsy drugs market: Alkermes Public Ltd. Co., Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., BIOPROJET, Cadila Pharmaceuticals Ltd., Don Valley Pharma, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals Plc, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., SHIONOGI Co. Ltd., Somacare, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancement in narcolepsy treatment."
According to the report, one of the major drivers for this market is the rising product launches and clinical trials.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alkermes Public Ltd. Co.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Avadel Pharmaceuticals plc
- Axsome Therapeutics Inc.
- BIOPROJET
- Cadila Pharmaceuticals Ltd.
- Don Valley Pharma
- Graymark Healthcare Inc.
- Jabs Biotech Pvt. Ltd.
- Jazz Pharmaceuticals Plc
- Luckys Pharma Pvt. Ltd.
- Midas Pharma GmbH
- Orbion Pharmaceuticals Pvt. Ltd.
- SHIONOGI Co. Ltd.
- Somacare
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- XWPharma Ltd.
